Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Rapid Diagnosis of Severe Kidney Damage – New Biomarkers Tested

16.01.2012
How does a doctor determine whether or not an emergency-room patient has acute kidney injury?

Using tests currently available in the hospital, this question is often difficult to answer. A large multicenter study by clinicians of the Experimental and Clinical Research Center (ECRC), a joint cooperation between the Max Delbrück Center (MDC), the Charité – Universitätsmedizin Berlin, the Helios Hospital (all in Berlin, Germany), and two hospitals in the U.S. has now shown that a urine test for proteins excreted by a damaged kidney helps to swiftly identify high-risk patients (Journal of the American College of Cardiology, online, 9. January 2012)*.

“There are no typical symptoms for acute kidney injury,” said Professor Kai Schmidt-Ott. “Nevertheless it is very important for the doctor to rapidly determine whether or not a patient has acute kidney injury” stressed the nephrologist from the Charité, who leads a research group at the MDC. Jonathan Barasch, Associate Professor of Medicine and Cell Biology at Columbia University and senior author of the paper commented: “When a patient presents to the Emergency Department and a blood test identifies an abnormal creatinine value, it is difficult to know whether the patient needs to be hospitalized because of ongoing intrinsic acute kidney injury (a potentially fatal disease) or whether the patient needs to be sent home after intravenous or oral fluids and later examined at an outpatient clinic.

This study, based on earlier studies by Professor Thomas L. Nickolas and Professor Schmidt-Ott, demonstrates the strength of association of the novel biomarker neutrophil gelatinase- associated lipocalin (NGAL) with intrinsic acute kidney injury and not simple volume depletion or more indolent forms of chronic kidney disease”, Prof. Barasch said. “Furthermore, the study demonstrates that NGAL and a second biomarker, kidney-injury molecule-1 (Kim1), predict poor outcomes during hospitalization, even days after the initial measurements.”

“In the initial stage of acute kidney injury, we may have most room for improvement of our current clinical practice” Professor Schmidt-Ott points out. In cases of advanced acute kidney injury, dialysis treatment is required. Many patients with severe acute kidney injury die in the hospital. Statistics illustrate how extensive the problem is. In the U.S. alone, one million patients are diagnosed every year with severe acute kidney injury. According to data of the German Society of Nephrology, there are currently around 70 000 dialysis patients in Germany; and this number is on the increase.

Currently, only the serum creatinine level is used for the diagnosis of acute kidney injury. Creatinine is a molecule that is normally excreted via the kidney, but accumulates in the blood when kidney function is impaired. “However, an elevated creatinine level is not a direct measure of kidney damage,” Professor Schmidt-Ott explained. “Thus, a prolonged slight-hypoperfused kidney can lead to a significant increase in serum creatinine, although the kidney tissue is not damaged. This functional impairment of the kidney usually responds well to treatment. The patients receive an electrolyte solution or have to stop taking the medications that damage the kidneys. In contrast, tissue damage in the kidney has a significantly worse prognosis. Nevertheless, serum creatinine values in the emergency room are of limited value because after kidney damage, 24 to 48 hours may elapse before serum creatinine values accumulate in the blood. Thus, at-risk patients remain undetected. That is why there is an urgent need for more accurate biomarkers of tissue damage in the kidney.”

Research has indicated that damaged kidneys synthesize specific proteins. In previous smaller studies, researchers investigated whether or not these proteins could serve as biomarkers to identify high-risk patients with kidney tissue damage. During the past three years, Professor Nickolas and Professor Barasch (Columbia University) and Professor Schmidt-Ott and Professor Friedrich C. Luft (both ECRC), pursued this question in a large-scale study. The researchers in Berlin and New York took a single measure of five urinary biomarkers from almost 1700 emergency room patients upon their admission to the hospital.

The investigators found that primarily the two putative biomarkers, NGAL and KIM-1, were useful in providing an early risk assessment. If both NGAL and KIM-1 levels are low, the patient’s risk of dying in the hospital or requiring dialysis treatment is likewise low. In contrast, high levels indicate the risk of acute kidney damage. If a doctor bases the diagnosis both on these biomarker readings and the serum creatinine levels, a more exact assessment of the individual risk is possible, according to Professor Schmidt-Ott, who is also adjunct assistant professor at Columbia University. This finding could quickly help emergency room doctors to devise an adequate treatment strategy for the patient.

But it is still not clear whether or not all patients admitted to an emergency room should be tested for these biomarkers. Perhaps only certain patients, for example diabetics or patients with high blood pressure, who are at high risk for acute kidney injury should be included. Furthermore, whether or not these biomarkers actually influence the individual treatment outcome is uncertain. As Professor Schmidt-Ott concluded, further studies are needed to answer these questions.

*Diagnostic and Prognostic Stratification in the Emergency Department Using Urinary Biomarkers of Nephron Damage - A Multicenter Prospective Cohort Study

Thomas L. Nickolas*†1, Kai M. Schmidt-Ott*†2,3, Pietro Canetta1, Catherine Forster1, Eugenia Singer2,3, Meghan Sise1, Antje Elger2, Omar Maarouf4, David Antonio Sola-Del Valle1, Matthew O’Rourke1, Evan Sherman1, Peter Lee1, Abdallah Geara1, Philip Imus1, Achuta Guddati1, Allison Polland1, Wasiq Rahman1, Saban Elitok3, Nasir Malik1, James Giglio1, Suzanne El-Sayegh4, Prasad Devarajan5, Sudarshan Hebbar6, Subodh J. Saggi4, Barry Hahn4, Ralph Kettritz2,3, Friedrich C. Luft2,3, and Jonathan Barasch1

1 Columbia University College of Physicians and Surgeons, New York, NY, USA
2 Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany
3 Helios Clinics, Berlin, Germany
4 Staten Island University Hospital, Staten Island, NY, USA
5 Cincinnati Childrens Hospital, Cincinnati, OH, USA
*† Co-first and co-corresponding authors
Contact:
Barbara Bachtler
Press Department
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
in the Helmholtz Association
Robert-Rössle-Straße 10
13125 Berlin
Phone: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
e-mail: presse@mdc-berlin.de

Barbara Bachtler | Max-Delbrück-Centrum
Further information:
http://www.mdc-berlin.de/
http://www.cumc.columbia.edu/newsroom

More articles from Life Sciences:

nachricht Bacteria as pacemaker for the intestine
22.11.2017 | Christian-Albrechts-Universität zu Kiel

nachricht Researchers identify how bacterium survives in oxygen-poor environments
22.11.2017 | Columbia University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Corporate coworking as a driver of innovation

22.11.2017 | Business and Finance

PPPL scientists deliver new high-resolution diagnostic to national laser facility

22.11.2017 | Physics and Astronomy

Quantum optics allows us to abandon expensive lasers in spectroscopy

22.11.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>